You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Decentralized, Public, and Mobile-Based Sidewalk Inventory Tool
SBC: KNOWLEDGE BASED SYSTEMS INC Topic: 142FH1Knowledge Based Systems, Inc. (KBSI) is pleased to propose the further design and development of MySidewalk mobile application facilitating the crowd-sourced collection of sidewalk inventory and condition data. The MySidewalk application utilizes advances in social networks and data mining to provide integrated sidewalk datasets. Phase I and II research was facilitated by inputs from City of Colle ...
SBIR Phase II 2019 Department of Transportation -
SBIR TOPIC 97- PHASE II- MINIMALLY INVASIVE TEST FOR CHEMOTHERAPY-INDUCED CARDIOTOXICITY
SBC: ACCEL DIAGNOSTICS, LLC Topic: NHLBICardiovascular toxicityCVTxis a serious short and long term complication of many anti cancer chemotherapeutic regimensZamoranoLancellotti et alIn this PhaseSBIR submission to continue the development and validation of Accel Diagnosticsminimally invasiverapidcost effective and connected blood testthe pScreen CVTx TMfor the early detection and continuous of chemotheropy induced CVTx
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Rapid, Accurate Point-of-Care Test for Gonorrhea and Determination of Antimicrobial Susceptibility
SBC: AI BIOSCIENCES, INC. Topic: NIAIDAntimicrobial resistant gonorrheacaused by Neisseria gonorrhoeaeNGhas become an urgent threat for global public healthThe goal of this project is to develop a one hour point of care diagnosticPOCtest capable of identifying NGand determining the infecting strain s susceptibility to antibioticsAI Biosciences plans to achieve this goal by expanding the capability of its POC system being developed for ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Advanced development of a novel nanoparticle conjugate vaccine for Salmonella Paratyphi A
SBC: KJ BIOSCIENCES LLC Topic: NIAIDSalmonella Paratyphi ASParatyphi Ais a major cause of life threatening enteric feverThere is no vaccine available against this pathogenIn the SBIR phase I studieswe have successfully demonstrated the technical feasibility of a novel nanoparticle conjugate vaccine candidate for SParatyphi AIt is based on O polysaccharideOPSantigen conjugated to a novel and highly advantageous nanoparticle protein c ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Aptamer Affinity Reagents to Immune Targets in Non-human Disease Models
SBC: BASE PAIR BIOTECHNOLOGIES INC Topic: NIAIDThis goal of this program is to address the limited availability of reagentsantibodiesproteinsligandsfor the identification and discrimination of immune cells and the characterization of immune responses in nonmammalian models and mammalian models for which immunologic reagents are limitede gguinea pigferretcotton ratFor examplethe progression of disease that follows infection of guinea pigs with ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
NCATS SBIR 2019 PHASE I PROPOSALS TOPIC 018 ENTITLED NON-PDMS BIOCOMPATIBLE ALTERNATIVES FOR ORGANS-ON-CHIPS
SBC: LYNNTECH INC. Topic: NIDAMicrofluidic organ on a chipOOCsystems offer a distinct advantage over existing in vitro systems through incorporation of micro architecture to a cultured cell line sthat structurely and mechanically mimic more closely in vivo physiological conditions in an in vitro constructThese OOC devices are typically constructed from polydimethylsiloxanePDMShoweverPDMS has several drawbacks that can impact t ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
TOPIC 386: NOVEL ORALLY BIOAVAILABLE PDE-CATENIN INHIBITOR CONCENTRATES IN LUNG FOR CANCER CHEMOPREVENTION
SBC: ADT Pharmaceuticals, LLC Topic: NCIThis application is based on ADT Pharmaceuticalsdiscoveries thatthe cGMP degrading phosphodiesterase isozymephosphodiesteraseAPDEis overexpressed during early stages of tumorigenesisgenetic knockdown of PDEresults in selective apoptosis of tumor cells by activating cGMP PKG signalingandsmall molecule inhibitors of PDEinduce apoptosis by PKG phosphorylation of oncogeniccateninthereby suppressing Tc ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
STING Inhibitor Discovery for Rare and Common Autoimmune Diseases
SBC: DISCOVERYBIOMED, INC. Topic: NIAIDPrincipal Investigators for Small BusinessDiscoveryBioMedIncDBMand Nitor TherapeuticsIncNitorProject Summary Abstract The over arching commercial goal for this Nitor TherapeuticsIncNitorand DiscoveryBioMedIncDBMcollaboration is to discover and validate Stimulator of Interferon Genes orSTINGinhibitor ligands in a novel high throughput screeningHTSand validation based Critical Path of bioassaysAberr ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Rodents Derived Synthetic Blood Brain Barrier Models for Chemical Toxicity Screening
SBC: CFD RESEARCH CORPORATION Topic: NIEHSAbstractThe overall goal of this study is to develop and demonstrate a novelpredictive in vitro organotypicD culture models of the blood brain barrierBBBderived from rodents for chemical toxicity screeningIn contrast with current Transwell based static and microfluidic assaysour commercially available SynBBB model enables real time visualization and quantitation of transport permeation under physi ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Preformulation and formulation development of Fenrock, an Abuse-resistant Fentanyl Transdermal Patch
SBC: PAIN THERAPEUTICS, INC. Topic: NIDAProject Summary Abstract Under this Fast Track proposalwe will develop Fenrockan abuse deterrent transdermal fentanyl patch based on our proprietary co crystal of naltrexoneNTXand its carefully selected conformermethyl furfuralMFFThis NTXMFFco crystalNTX Cohas the desired properties to stay in a crystalline solid form in the patch when applied to skin as intended but to dissociate to deliver NTX w ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health